A Study to Evaluate the Safety and Efficacy of ATHENA CAR-T in Subjects With Systemic Lupus Erythematosus

NCT06373991 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Lupus Erythematosus, Systemic

Interventions

BIOLOGICAL: ATHENA CAR-T
DRUG: Fludarabine
DRUG: Cyclophosphamide

Sponsor

EdiGene Inc.

Collaborators

[object Object]
[object Object]